Www.pbm.va.gov

In 2 RA studies, the percentage of patients who developed new positive ANA (titer > 1:40) was higher in etanercept-treated patients vs. placebo (11 vs. 5%); the percent of patients who developed new positive anti-double-strand DNA antibodies was higher in the etanercept-treated patients vs. placebo. ................
................